External validation of a prognostic model predicting overall survival in metastatic castrate-resistant prostate cancer patients treated with abiraterone

MLA

Emily Grist, et al. “External Validation of a Prognostic Model Predicting Overall Survival in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Abiraterone.” European Urology, vol. 66, no. 1, Feb. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5334ec598ffac5896fc6dfcad6bba1ad&authtype=sso&custid=ns315887.

APA

Emily Grist, Alan D. Smith, Diletta Bianchini, Amelia Altavilla, Roberta Ferraldeschi, Joaquin Mateo, Johann S. de Bono, David Lorente, Praful Ravi, Spyridon Sideris, Sophia Wong, Gerhardt Attard, & Zafeiris Zafeiriou. (2014). External validation of a prognostic model predicting overall survival in metastatic castrate-resistant prostate cancer patients treated with abiraterone. European Urology, 66(1).

Chicago

Emily Grist, Alan D. Smith, Diletta Bianchini, Amelia Altavilla, Roberta Ferraldeschi, Joaquin Mateo, Johann S. de Bono, et al. 2014. “External Validation of a Prognostic Model Predicting Overall Survival in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Abiraterone.” European Urology 66 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5334ec598ffac5896fc6dfcad6bba1ad&authtype=sso&custid=ns315887.